Key Points Dynavax Technologies (NASDAQ:DVAX) exceeded analyst expectations in Q2 2025, reporting GAAP revenue of $95.4 million and GAAP diluted EPS of $0.14. HEPLISAV-B, Dynavax's two-dose adult ...

Q2 2025 Management View CEO Hilton H. Schlosberg highlighted a record-setting quarter: "our second quarter net sales of $2.11 billion are a quarterly record that crossed the $2 billion threshold for ...

Get insights from Ligand Pharmaceuticals' Q2 2025 earnings—57% royalty revenue growth, raised guidance, and key partnerships driving long-term growth.

Key Points Karat Packaging (NASDAQ:KRT) achieved quarterly records for both revenue and net income in Q2 2025, modestly beat analyst expectations on a non-GAAP basis. Gross margin (GAAP) improved to ...

Pipeline Regulatory Progress -- Two risk-adjusted product launches (AMP-002 and AMP-015) are included in the flat full-year ...

North America quarterly run-rate average unit volume (AUV) amounted to $659,000 in Q2, compared to $638,000 in the 2024 Q2 ...

Software development tools maker JFrog (NASDAQ:FROG) announced in Q2 CY2025, with sales up 23.5% year on year to $127.2 ...

Delivers Second Quarter Results in Line with and Above Guidance Ranges Revises Full Year 2025 Revenue Outlook and Reiterates ...

Successfully launched AYON Body Contouring System™ to key surgeons in critical geographies; plan for commercial launch in September 2025Initiated commercial sales of Renuvion® in China with strong ...

Kimberly-Clark is undervalued despite improving revenue, higher margins, and a 4% dividend yield. Read more on why KMB is an ...

Titan reported a 53% hike in its net profit to ₹1,091 crore in the April-June quarter of the 2025-26 fiscal year. The company ...

The Japanese automaker estimates that it will lose billions due to the impact of the Trump administration's tariffs.